These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29386880)

  • 1. Human L- and M-opsins restore M-cone function in a mouse model for human blue cone monochromacy.
    Deng WT; Li J; Zhu P; Chiodo VA; Smith WC; Freedman B; Baehr W; Pang J; Hauswirth WW
    Mol Vis; 2018; 24():17-28. PubMed ID: 29386880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rescue of M-cone Function in Aged Opn1mw-/- Mice, a Model for Late-Stage Blue Cone Monochromacy.
    Deng WT; Li J; Zhu P; Freedman B; Smith WC; Baehr W; Hauswirth WW
    Invest Ophthalmol Vis Sci; 2019 Aug; 60(10):3644-3651. PubMed ID: 31469404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Therapy in
    Ma X; Sechrest ER; Fajardo D; Zhu P; Dyka F; Wang Y; Lobanova E; Boye SE; Baehr W; Deng WT
    Hum Gene Ther; 2022 Jul; 33(13-14):708-718. PubMed ID: 35272502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-based Therapy in a Mouse Model of Blue Cone Monochromacy.
    Zhang Y; Deng WT; Du W; Zhu P; Li J; Xu F; Sun J; Gerstner CD; Baehr W; Boye SL; Zhao C; Hauswirth WW; Pang JJ
    Sci Rep; 2017 Jul; 7(1):6690. PubMed ID: 28751656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blue cone monochromacy and gene therapy.
    Sechrest ER; Chmelik K; Tan WD; Deng WT
    Vision Res; 2023 Jul; 208():108221. PubMed ID: 37001420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cone visual pigment deletions spare sufficient photoreceptors to warrant gene therapy.
    Cideciyan AV; Hufnagel RB; Carroll J; Sumaroka A; Luo X; Schwartz SB; Dubra A; Land M; Michaelides M; Gardner JC; Hardcastle AJ; Moore AT; Sisk RA; Ahmed ZM; Kohl S; Wissinger B; Jacobson SG
    Hum Gene Ther; 2013 Dec; 24(12):993-1006. PubMed ID: 24067079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blue cone monochromacy: visual function and efficacy outcome measures for clinical trials.
    Luo X; Cideciyan AV; Iannaccone A; Roman AJ; Ditta LC; Jennings BJ; Yatsenko SA; Sheplock R; Sumaroka A; Swider M; Schwartz SB; Wissinger B; Kohl S; Jacobson SG
    PLoS One; 2015; 10(4):e0125700. PubMed ID: 25909963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cone opsin mutations on retinal structure and the integrity of the photoreceptor mosaic.
    Carroll J; Dubra A; Gardner JC; Mizrahi-Meissonnier L; Cooper RF; Dubis AM; Nordgren R; Genead M; Connor TB; Stepien KE; Sharon D; Hunt DM; Banin E; Hardcastle AJ; Moore AT; Williams DR; Fishman G; Neitz J; Neitz M; Michaelides M
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8006-15. PubMed ID: 23139274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blue Cone Monochromatism with Foveal Hypoplasia Caused by the Concomitant Effect of Variants in
    Iarossi G; Coppè AM; Passarelli C; Maltese PE; Sinibaldi L; Cappelli A; Cetola S; Novelli A; Buzzonetti L
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual Cone Structure in Patients With X-Linked Cone Opsin Mutations.
    Patterson EJ; Kalitzeos A; Kasilian M; Gardner JC; Neitz J; Hardcastle AJ; Neitz M; Carroll J; Michaelides M
    Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):4238-4248. PubMed ID: 30128495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting gene expression to cones with human cone opsin promoters in recombinant AAV.
    Komáromy AM; Alexander JJ; Cooper AE; Chiodo VA; Glushakova LG; Acland GM; Hauswirth WW; Aguirre GD
    Gene Ther; 2008 Jul; 15(14):1049-55. PubMed ID: 18337838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel
    Stingl K; Baumann B; De Angeli P; Vincent A; Héon E; Cordonnier M; De Baere E; Raskin S; Sato MT; Shiokawa N; Kohl S; Wissinger B
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 73,128 bp de novo deletion encompassing the OPN1LW/OPN1MW gene cluster in sporadic Blue Cone Monochromacy: a case report.
    Buena-Atienza E; Nasser F; Kohl S; Wissinger B
    BMC Med Genet; 2018 Jun; 19(1):107. PubMed ID: 29940872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human blue-opsin promoter preferentially targets reporter gene expression to rat s-cone photoreceptors.
    Glushakova LG; Timmers AM; Pang J; Teusner JT; Hauswirth WW
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3505-13. PubMed ID: 16877422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The landscape of submicroscopic structural variants at the
    Wissinger B; Baumann B; Buena-Atienza E; Ravesh Z; Cideciyan AV; Stingl K; Audo I; Meunier I; Bocquet B; Traboulsi EI; Hardcastle AJ; Gardner JC; Michaelides M; Branham KE; Rosenberg T; Andreasson S; Dollfus H; Birch D; Vincent AL; Martorell L; Català Mora J; Kellner U; Rüther K; Lorenz B; Preising MN; Manfredini E; Zarate YA; Vijzelaar R; Zrenner E; Jacobson SG; Kohl S
    Proc Natl Acad Sci U S A; 2022 Jul; 119(27):e2115538119. PubMed ID: 35759666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myopia and Late-Onset Progressive Cone Dystrophy Associate to LVAVA/MVAVA Exon 3 Interchange Haplotypes of Opsin Genes on Chromosome X.
    Orosz O; Rajta I; Vajas A; Takács L; Csutak A; Fodor M; Kolozsvári B; Resch M; Sényi K; Lesch B; Szabó V; Berta A; Balogh I; Losonczy G
    Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1834-1842. PubMed ID: 28358949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foveal Cone Structure in Patients With Blue Cone Monochromacy.
    Patterson EJ; Kalitzeos A; Kane TM; Singh N; Kreis J; Pennesi ME; Hardcastle AJ; Neitz J; Neitz M; Michaelides M; Carroll J
    Invest Ophthalmol Vis Sci; 2022 Oct; 63(11):23. PubMed ID: 36301530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype determination of the OPN1LW/OPN1MW genes: novel disease-causing mechanisms in Japanese patients with blue cone monochromacy.
    Katagiri S; Iwasa M; Hayashi T; Hosono K; Yamashita T; Kuniyoshi K; Ueno S; Kondo M; Ueyama H; Ogita H; Shichida Y; Inagaki H; Kurahashi H; Kondo H; Ohji M; Hotta Y; Nakano T
    Sci Rep; 2018 Jul; 8(1):11507. PubMed ID: 30065301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of ADVM-062, a novel intravitreal gene therapy vector for the treatment of blue cone monochromacy.
    Hanna K; Nieves J; Dowd C; Bender KO; Sharma P; Singh B; Renz M; Ver Hoeve JN; Cepeda D; Gelfman CM; Riley BE; Grishanin RN
    Mol Ther; 2023 Jul; 31(7):2014-2027. PubMed ID: 36932675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does recombinant adeno-associated virus-vectored proximal region of mouse rhodopsin promoter support only rod-type specific expression in vivo?
    Glushakova LG; Timmers AM; Issa TM; Cortez NG; Pang J; Teusner JT; Hauswirth WW
    Mol Vis; 2006 Apr; 12():298-309. PubMed ID: 16617297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.